Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>News>This Article

World Water Monitoring Day 2012: Microbes a Major Threat to Potable Water

Published: Friday, September 21, 2012
Last Updated: Friday, September 21, 2012
Bookmark and Share
Non-profit trying to address the issue by increasing access to safe drinking water.

September 18 is World Water Monitoring Day, an event coordinated by the Water Environment Federation and International Water Association as part of the World Water Monitoring Challenge (WWMC).

The event encourages people, especially children, to test their local water sources for a variety of characteristics, such as temperature, pH, and dissolved oxygen content.

The initiative does an excellent job highlighting the importance of keeping waterways clean, but World Water Monitoring Day fails to address one of the biggest threats to potable water - microorganisms.

The World Health Organization (WHO) states: “Infectious diseases caused by pathogenic bacteria, viruses, protozoa, and helminths are the most common and wide-spread health risk associated with drinking water.”

Drinking water contaminated with pathogenic organisms is practically a non-issue in developed countries.

In fact, waterborne disease outbreaks are major news events when they do occur, as when the 1993 outbreak in Milwaukee, WI, of Cryptosporidium, a protozoan infection, that made over 400,000 people ill.

Cholera, caused by the bacterium Vibrio cholerae, is a notorious waterborne disease.

In the 19th century, cholera was one of the most widespread and deadly diseases, but it is no longer a threat in the United States or Europe.

Unfortunately, cholera is still a significant cause of morbidity and mortality in the developing world.

The WHO estimates that cholera infects 3–5 million people and is responsible for approximately 100,000 deaths per year.

Therefore, the morbidity and mortality associated with cholera is much less than malaria or tuberculosis, but when the burdens of all waterborne diarrheal disease are combined, the WHO estimates that they are responsible for over 4% of the total disability-adjusted life year (DALY) global burden of disease.

Organizations such as the non-profit are trying to address this issue by increasing access to safe drinking water. has formed strategic partnerships with corporate foundations, including PepsiCo, Caterpillar, and MasterCard.

These alliances have helped make significant progress, but it estimates that 50% of water projects fail due to a lack of community involvement.

Collaboration between and WWMC could overcome this concern.

WWMC has achieved international involvement, including several countries that have elevated incidences of waterborne disease (e.g., India, Cameroon, and Kenya).

A WWMC/ partnership would enable the organizations to focus on their strengths.

Hopefully the two groups can collaborate soon as UNICEF estimates that a child dies from water-associated diarrhea every 20 seconds.

WWMC could foster community support through education and outreach, and could coordinate and help finance the water projects using its corporate contacts.

This synergy could also help reduce costs, which would enable more funding for this mission.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,600+ scientific posters on ePosters
  • More Than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Personalized Screening for Ovarian Cancer
With 60% of women diagnosed with ovarian cancer dying within five years of diagnosis there has been considerable efforts to try to detect the disease at an earlier stage.
Tuesday, June 30, 2015
Promising Malaria and Dengue Vaccines Will Not Defeat Diseases
Although vaccination is a key part of the control of disease GlobalData stress the importance of a multi-dimensional approach.
Friday, May 22, 2015
Big R&D Investment Trend as Mid-Cap Biotechs Push to Get Drugs to Market
20% of overall increase in R&D expenditure in just a year.
Thursday, March 07, 2013
Pfizer Contemplates $2 Billion Acquisition of Strides’ Agila Unit
As drug makers continue to jostle for market share and deal with declining revenues from their off-patent blockbuster drugs, M&A activity is showing no indication of slowing down in 2013.
Thursday, January 17, 2013
The Fall from Grace of Peregrine Pharmaceuticals
On September 24, 2012, the company announced the discovery of ‘major data discrepancies’ between reported results and patient treatment code assignments.
Wednesday, October 17, 2012
T-DM1 Demonstrates Overall Survival Benefit in Metastatic Breast Cancer
Next target, FDA approval.
Thursday, August 30, 2012
Tofacitinib: Sacrificing Safety for Novelty?
FDA has extended the review period of tofacitinib by three months.
Wednesday, August 22, 2012
Heavyweight Battle: Buyer-Versus-Supplier Showdown in Childhood Vaccines
Federal judge moves forward with meningococcal vaccine antitrust suit against Sanofi.
Tuesday, August 21, 2012
Poor Healthcare Policies and Infrastructure, But India’s Pharma Market Continues to Boom
Country’s pharmaceutical industry continue to expand rapidly in the coming years.
Tuesday, August 21, 2012
The World’s First (Official) Biosimilar Antibody Goes to… Rheumatoid Arthritis
Remsima is the first officially approved biosimilar antibody for RA therapy.
Thursday, August 09, 2012
The World’s First (Official) Biosimilar Antibody Goes to… Rheumatoid Arthritis
Celltrion announces the approval of Remsima (CT-P13), a biosimilar antibody, by the Korean Food and Drug Administration.
Wednesday, August 08, 2012
Lifestyle and Infectious Diseases Encourage IVD Market in Emerging Countries
The market for IVD in the BRIC countries is expected to grow at a CAGR of 16% in 2018.
Friday, May 11, 2012
Dyeing to Paint the Alzheimer’s Brain
Alzheimer’s disease (AD) is characterized by beta-amyloid plaques. Most patients are diagnosed late-stage in the disease or are misdiagnosed with another form of dementia.
Thursday, April 12, 2012
Aplastic Anemia Patients in Need of New Treatment Options
New study explores the failings of current treatment options for aplastic anemia.
Friday, February 24, 2012
Scientific News
Researchers Develop Classification Model for Cancers Caused by KRAS
Most frequently mutated cancer gene help oncologists choose more effective cancer therapies.
Fixing Holes in the Heart Without Invasive Surgery
UV-light enabled catheter is a medical device which represents a major shift in how cardiac defects are repaired.
Chromosomal Chaos
Penn study forms basis for future precision medicine approaches for Sezary syndrome
Enzyme Malfunction May be Why Binge Drinking Can Lead to Alcoholism
A new study in mice shows that restoring the synthesis of a key brain chemical tied to inhibiting addictive behavior may help prevent alcohol cravings following binge drinking.
Key to Natural Detoxifier’s Reactivity Discovered
Results have implications for health, drug design and chemical synthesis.
New Treatment for Obesity Developed
Researchers at the University of Liverpool, working with a global healthcare company, have helped develop a new treatment for obesity.
New Protein Found in Immune Cells
Immunobiologists from the University of Freiburg discover Kidins220/ARMS in B cells and demonstrate its functions.
Will Brain Palpation Soon Be Possible?
Researchers have developed non-invasive brain imaging technique which provides the same information as physical palpation.
Shaking Up the Foundations of Epigenetics
Researchers at the Centre for Genomic Regulation (CRG) and the University of Barcelona (UB) published a study that challenges some of the current beliefs about epigenetics.
Groundbreaking Computer Program Diagnoses Cancer in Two Days
Researchers have combined genetics with computer science and created a new diagnostic technology can with 85 per cent certainty identify the source of the disease and thus target treatment and, ultimately, improve the prognosis for the patient.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,600+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos